• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎病毒感染在 20 年间导致肝细胞癌病因学中作用的相对下降:一项多中心意大利研究。

Relative decrease in the role played by hepatitis B virus infection in the aetiology of hepatocellular carcinoma during a 20-year period: a multicentre Italian study.

机构信息

Dipartimento di Medicina Interna, University of Genoa, Genoa, Italy.

出版信息

Liver Int. 2011 Feb;31(2):192-6. doi: 10.1111/j.1478-3231.2010.02409.x. Epub 2010 Dec 10.

DOI:10.1111/j.1478-3231.2010.02409.x
PMID:21143580
Abstract

BACKGROUND

Chronic hepatitis B virus (HBV) infection is one of the most frequent aetiological factors associated with the development of hepatocellular carcinoma (HCC).

AIM

This study evaluated the temporal trend in the aetiological role played by HBV infection alone in patients diagnosed with HCC during the last 20 years in Italy.

METHODS

Among the 2042 HCC patients included in the Italian Liver Cancer (ITA.LI.CA.) database, 346 had chronic HBV infection alone. We assessed the proportion of HCC patients with HBV infection in four quinquennia (1987-1991, 1992-1996, 1997-2001, 2002-2006) and evaluated their main clinical, virological and oncological characteristics across these periods.

RESULTS

Although the absolute number increased, the proportion of HBV-related HCC relatively decreased over time from 26.7% (47/176 patients) in 1987-1991 to 14.7% (127/862 patients) in 2002-2006 (P=0.0005). Patients' demographical, clinical and virological characteristics were similar across the four quinquennia. A greater proportion of patients was diagnosed with non-advanced HCC in more recent years (from 26% in 1987-1991 to 48% in 2002-2006, P=0.025), likely owing to a growing use of semiannual surveillance (from 63% in 1987-1991 to 80% in 2002-2006).

CONCLUSIONS

We observed a significant, relative decrease in the role played by chronic HBV infection alone in the determinism of HCC during the last 20 years. In recent years, more patients are diagnosed with non-advanced HCC probably owing to improvements in HCC detection.

摘要

背景

慢性乙型肝炎病毒(HBV)感染是导致肝细胞癌(HCC)发生的最常见病因之一。

目的

本研究评估了过去 20 年中意大利单独由 HBV 感染引起 HCC 的病因学作用的时间趋势。

方法

在意大利肝癌(ITA.LI.CA.)数据库中纳入的 2042 例 HCC 患者中,有 346 例为慢性 HBV 感染。我们评估了四个 5 年期间(1987-1991 年、1992-1996 年、1997-2001 年、2002-2006 年)中 HBV 感染 HCC 患者的比例,并评估了这些时期内他们的主要临床、病毒学和肿瘤学特征。

结果

尽管绝对数量有所增加,但随着时间的推移,HBV 相关 HCC 的比例相对下降,从 1987-1991 年的 26.7%(47/176 例)降至 2002-2006 年的 14.7%(127/862 例)(P=0.0005)。四个 5 年期间患者的人口统计学、临床和病毒学特征相似。近年来,更多的患者被诊断为非晚期 HCC(从 1987-1991 年的 26%增加至 2002-2006 年的 48%,P=0.025),这可能归因于半年一次的监测使用率的增加(从 1987-1991 年的 63%增加至 2002-2006 年的 80%)。

结论

在过去 20 年中,我们观察到单独由慢性 HBV 感染引起 HCC 的作用显著下降,相对降低。近年来,更多的患者被诊断为非晚期 HCC,可能是由于 HCC 检测水平的提高。

相似文献

1
Relative decrease in the role played by hepatitis B virus infection in the aetiology of hepatocellular carcinoma during a 20-year period: a multicentre Italian study.乙型肝炎病毒感染在 20 年间导致肝细胞癌病因学中作用的相对下降:一项多中心意大利研究。
Liver Int. 2011 Feb;31(2):192-6. doi: 10.1111/j.1478-3231.2010.02409.x. Epub 2010 Dec 10.
2
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.隐匿性乙型肝炎病毒感染与慢性丙型肝炎患者肝细胞癌的发生有关。
Cancer. 2006 Mar 15;106(6):1326-30. doi: 10.1002/cncr.21702.
3
Hepatocellular carcinoma in individuals with HBV infection or HBV-HCV co-infection in a low endemic country.低流行国家中感染乙肝病毒(HBV)或同时感染乙肝病毒和丙肝病毒(HBV-HCV)个体的肝细胞癌
Scand J Gastroenterol. 2010 Aug;45(7-8):944-52. doi: 10.3109/00365521003770251.
4
The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.乙型肝炎病毒既往感染在日本HBs抗原阴性及抗-HCV阴性肝细胞癌患者中的作用:病因学及分子生物学研究
J Exp Clin Cancer Res. 1999 Sep;18(3):379-89.
5
Does hepatitis B virus play a role in primary liver cancer in children of Western countries?在西方国家儿童的原发性肝癌中,乙型肝炎病毒是否起作用?
Cancer Detect Prev. 1991;15(5):363-8.
6
High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.尼泊尔肝硬化或肝细胞癌患者中乙肝病毒感染及下腔静脉阻塞的高患病率。
J Gastroenterol Hepatol. 2007 Nov;22(11):1921-8. doi: 10.1111/j.1440-1746.2006.04611.x.
7
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.肝硬化病因对监测期间诊断为肝细胞癌患者生存的影响。
Am J Gastroenterol. 2007 May;102(5):1022-31. doi: 10.1111/j.1572-0241.2007.01100.x. Epub 2007 Feb 21.
8
Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.美国的肝细胞癌:病因学考量。乙型肝炎抗原的定位。
Gastroenterology. 1979 Feb;76(2):279-87.
9
[Hepatocellular carcinoma, hepatitis B virus and the immune system].[肝细胞癌、乙型肝炎病毒与免疫系统]
Schweiz Med Wochenschr. 1986 Aug 23;116(34):1133-45.
10
[Epidemiology of hepatocellular carcinoma].[肝细胞癌的流行病学]
Minerva Gastroenterol Dietol. 1991 Apr-Jun;37(2):73-84.

引用本文的文献

1
Silencing of microRNA-210 inhibits the progression of liver cancer and hepatitis B virus-associated liver cancer via targeting EGR3.miR-210 的沉默通过靶向 EGR3 抑制肝癌和乙型肝炎病毒相关性肝癌的进展。
BMC Med Genet. 2020 Mar 6;21(1):48. doi: 10.1186/s12881-020-0974-9.